Agilent Technologies, Inc. - Diagnostics and Genomics SS CD GlasgowCancerPlus, PC-pool, 96A
The SureSelect Cancer All-In-One Glasgow Cancer Plus Panel (part number 5191-6954) from Agilent Technologies is a targeted next-generation sequencing (NGS) solution designed for comprehensive cancer genomic profiling. This panel enables the detection of key somatic variants across a broad range of cancer-related genes, supporting both research and clinical applications. The kit is provided as a pre-capture pool format for 96 reactions, streamlining library preparation and hybridization workflows. It is optimized for high sensitivity and specificity, ensuring reliable variant detection from challenging sample types, including formalin-fixed, paraffin-embedded (FFPE) tissues.